ITBO980596A0 - Preparazione per la veicolazione di principi attivi basata su acidi gr assi polinsaturi del gruppo omega 3 . - Google Patents

Preparazione per la veicolazione di principi attivi basata su acidi gr assi polinsaturi del gruppo omega 3 .

Info

Publication number
ITBO980596A0
ITBO980596A0 IT98BO000596A ITBO980596A ITBO980596A0 IT BO980596 A0 ITBO980596 A0 IT BO980596A0 IT 98BO000596 A IT98BO000596 A IT 98BO000596A IT BO980596 A ITBO980596 A IT BO980596A IT BO980596 A0 ITBO980596 A0 IT BO980596A0
Authority
IT
Italy
Prior art keywords
omega
delivery
preparation
group
fatty acids
Prior art date
Application number
IT98BO000596A
Other languages
English (en)
Inventor
Janos Feher
Grazia Sears
Original Assignee
Danital Italia S R L
Janos Feher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11343466&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITBO980596(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Danital Italia S R L, Janos Feher filed Critical Danital Italia S R L
Priority to IT1998BO000596A priority Critical patent/IT1304406B1/it
Publication of ITBO980596A0 publication Critical patent/ITBO980596A0/it
Priority to DK99954343T priority patent/DK1123093T3/da
Priority to PT99954343T priority patent/PT1123093E/pt
Priority to DE69907010T priority patent/DE69907010T2/de
Priority to EP99954343A priority patent/EP1123093B1/en
Priority to AU10746/00A priority patent/AU1074600A/en
Priority to ES99954343T priority patent/ES2196874T3/es
Priority to AT99954343T priority patent/ATE237323T1/de
Priority to PCT/IT1999/000331 priority patent/WO2000023069A1/en
Priority to US09/807,918 priority patent/US6417233B1/en
Priority to ARP990105327A priority patent/AR023338A1/es
Publication of ITBO980596A1 publication Critical patent/ITBO980596A1/it
Publication of IT1304406B1 publication Critical patent/IT1304406B1/it
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
IT1998BO000596A 1998-10-21 1998-10-21 Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3. IT1304406B1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT1998BO000596A IT1304406B1 (it) 1998-10-21 1998-10-21 Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
US09/807,918 US6417233B1 (en) 1998-10-21 1999-10-19 Ubiguinone-containing composition suitable for promoting enhanced intramitochondrial transportation of ubiguinones and methods of using same
AU10746/00A AU1074600A (en) 1998-10-21 1999-10-19 Ubiguinone-containing composition suitable for promoting enhanced intramitochondrial transportation of ubiquinones and methods of using same
PT99954343T PT1123093E (pt) 1998-10-21 1999-10-19 Composicao contendo ubiquinona adequada para promocao do transporte intramitocondrial acrescido de ubiquinonas e metodo para a sua utilizacao
DE69907010T DE69907010T2 (de) 1998-10-21 1999-10-19 Ubichinon enthaltende zusammensetzung geeignet zur förderung des erhöhten intramitochondrialen transportes von ubichinonen und verfahren deren verwendung
EP99954343A EP1123093B1 (en) 1998-10-21 1999-10-19 Ubiquinone-containing composition suitable for promoting enhanced intramitochondrial transportation of ubiquinones and methods of using same
DK99954343T DK1123093T3 (da) 1998-10-21 1999-10-19 Ubiquinonholdig sammensætning egnet til at fremme øget intramitochondrisk transport af ubiquinoner og fremgangsmåder til at anvende det
ES99954343T ES2196874T3 (es) 1998-10-21 1999-10-19 Composicion que contiene ubiquinona adecuada para promover el transporte intramitocondrial de ubiquinosas y procedimientos de uso de dicho composicion.
AT99954343T ATE237323T1 (de) 1998-10-21 1999-10-19 Ubichinon enthaltende zusammensetzung geeignet zur förderung des erhöhten intramitochondrialen transportes von ubichinonen und verfahren deren verwendung
PCT/IT1999/000331 WO2000023069A1 (en) 1998-10-21 1999-10-19 Ubiguinone-containing composition suitable for promoting enhanced intramitochondrial transportation of ubiquinones and methods of using same
ARP990105327A AR023338A1 (es) 1998-10-21 1999-10-21 Composicion conteniendo ubiquinona adecuada para promover el transporte mejorado intramitocondrial de ubiquinonas y uso de la misma para preparar unacomposicion alimenticia/farmacologica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998BO000596A IT1304406B1 (it) 1998-10-21 1998-10-21 Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.

Publications (3)

Publication Number Publication Date
ITBO980596A0 true ITBO980596A0 (it) 1998-10-21
ITBO980596A1 ITBO980596A1 (it) 2000-04-21
IT1304406B1 IT1304406B1 (it) 2001-03-19

Family

ID=11343466

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1998BO000596A IT1304406B1 (it) 1998-10-21 1998-10-21 Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.

Country Status (11)

Country Link
US (1) US6417233B1 (it)
EP (1) EP1123093B1 (it)
AR (1) AR023338A1 (it)
AT (1) ATE237323T1 (it)
AU (1) AU1074600A (it)
DE (1) DE69907010T2 (it)
DK (1) DK1123093T3 (it)
ES (1) ES2196874T3 (it)
IT (1) IT1304406B1 (it)
PT (1) PT1123093E (it)
WO (1) WO2000023069A1 (it)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1307281B1 (it) 1999-11-25 2001-10-30 Simonelli Giuseppe Uso di ubichinone q10 per il trattamento locale e la prevenzione dipatalogie oftalmologiche secondarie alla terapia fotorefrattiva,
PL363426A1 (en) * 2001-03-09 2004-11-15 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
DE50100901D1 (de) * 2001-04-12 2003-12-11 Vesifact Ag Baar Coenzym Q10 enthaltende Mikroemulsion-Prekonzentrate und Mikroemulsionen
US6582723B2 (en) * 2001-05-03 2003-06-24 Wayne F. Gorsek Cancer immune composition for prevention and treatment of individuals
JP4603192B2 (ja) * 2001-05-10 2010-12-22 株式会社カネカ 毛髪頭皮用組成物
CN1268328C (zh) * 2001-05-30 2006-08-09 拉克斯戴尔有限公司 辅酶q与二十碳五烯酸(epa)
US7470659B2 (en) * 2001-12-07 2008-12-30 The Regents Of The University Of California Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM)
US20030229062A1 (en) * 2001-12-07 2003-12-11 The Regents Of The University Of California Treatments for age-related macular degeneration (AMD)
ITRM20010755A1 (it) 2001-12-20 2003-06-20 Simonelli Giuseppe Uso del chinone q10 per il trattamento delle malattie oculari.
TW200302056A (en) * 2002-01-18 2003-08-01 Kaneka Corp Method for stabilizing reduced coenzyme Q10 and composition therefor
US6974592B2 (en) * 2002-04-11 2005-12-13 Ocean Nutrition Canada Limited Encapsulated agglomeration of microcapsules and method for the preparation thereof
CA2471821C (en) * 2002-11-04 2006-04-25 Ocean Nutrition Canada Limited Microcapsules having multiple shells and method for the preparation thereof
US20040208939A1 (en) * 2003-04-18 2004-10-21 Barry Sears Novel dietary compositions to reduce inflammation
US7875291B1 (en) 2003-09-05 2011-01-25 Glu-Pro, Inc. Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
TW200524579A (en) * 2003-11-28 2005-08-01 Kaneka Corp Composition for protecting liver functions
AU2005204044B2 (en) * 2004-01-08 2010-07-22 Kaneka Corporation Antiaging composition
EP2371364B1 (en) 2004-01-22 2016-10-19 University of Miami Topical or intravenous co-enzyme q10 formulations for use in treating cancer
US7390507B2 (en) * 2004-04-13 2008-06-24 Ruwart Mary J Compositions and methods for the treatment of radiation burns and other traumatic skin conditions
DE102004041270A1 (de) * 2004-08-26 2006-03-02 Merz Pharma Gmbh & Co. Kgaa Ein Kapillar- Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung
US8034450B2 (en) * 2005-01-21 2011-10-11 Ocean Nutrition Canada Limited Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
CA2556520C (en) * 2005-01-27 2008-10-28 Ocean Nutrition Canada Ltd. Chromium-fatty acid compounds and methods of making and using thereof
DE602006011127D1 (de) 2005-01-27 2010-01-28 Ocean Nutrition Canada Ltd Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür
DK2471530T3 (en) 2005-06-01 2017-04-10 Edison Pharmaceuticals Inc REDOXACTIVE THERAPEUTIC AGENTS FOR THE TREATMENT OF MITOCONDARY DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS
US9968120B2 (en) * 2006-05-17 2018-05-15 Dsm Nutritional Products Ag Homogenized formulations containing microcapsules and methods of making and using thereof
DK1933821T3 (da) * 2005-09-15 2020-10-26 Ptc Therapeutics Inc Halevarianter af redox-aktive terapeutika til behandling af mitokondriesygdomme og andre tilstande og modulation af energibiomarkører
EP1957053A4 (en) * 2005-11-17 2012-03-28 Bioavailability Inc BIOKOMPATIBLE LATENT EMULSIFICATORS
JP2009520824A (ja) * 2005-12-20 2009-05-28 セネストラ エルエルシー オメガ３脂肪酸製剤
US20070184041A1 (en) * 2006-02-09 2007-08-09 Burja Adam M Methods and compositions related to production of coenzyme q10
US9278085B2 (en) 2006-02-22 2016-03-08 Edison Pharmaceuticals, Inc. Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
GB0604647D0 (en) 2006-03-08 2006-04-19 Shchepinov Mikhail Stabilized food supplements and their derivatives
KR20090029699A (ko) * 2006-04-07 2009-03-23 오션 뉴트리션 캐나다 리미티드 낮은 계면장력 물질을 가지는 에멀젼 및 마이크로캡슐, 제조방법 및 이용방법
US8491888B2 (en) * 2006-05-05 2013-07-23 Softgel Formulators, Inc. Highly absorbable coenzyme Q10 composition and method of producing same
WO2008017962A2 (en) * 2006-06-05 2008-02-14 Ocean Nutrition Canada Ltd. Microcapsules with improved shells
KR100801057B1 (ko) * 2006-07-18 2008-02-04 삼성전자주식회사 컬러 보정 블럭을 구비하는 ｃｍｏｓ 이미지 센서 및 그이미지 센싱 방법
US8894993B2 (en) * 2006-08-04 2014-11-25 Natreon Inc. Mitochondria-targeted antioxidants
CN101631542B (zh) * 2006-12-28 2011-12-21 三得利控股株式会社 神经再生剂
KR101454942B1 (ko) 2007-01-10 2014-10-27 디에스엠 뉴트리셔널 프라덕츠 아게 채식주의용 마이크로캡슐
HUP0700552A2 (en) * 2007-08-27 2009-03-30 Janos Dr Feher Method and composition inhibiting inflammation
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
KR100943652B1 (ko) * 2007-12-28 2010-02-25 (주)미토콘 생체이용율이 향상된 코엔자임큐10 함유 조성물
EA023827B1 (ru) 2008-04-11 2016-07-29 БЕРГ ЭлЭлСи Способ индуцирования апоптоза в клетке
US8535659B1 (en) 2008-05-27 2013-09-17 Argent Development Group, Llc Nutritional supplements for pregnant women
US8535660B1 (en) 2008-05-27 2013-09-17 Argent Development Group, Llc Nutritional supplements for pregnant women
EP2344142B1 (en) 2008-09-10 2024-06-26 PTC Therapeutics, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
IT1393419B1 (it) * 2009-03-19 2012-04-20 Medivis S R L Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
CN102413813B (zh) * 2009-03-24 2014-11-12 Adds制药有限责任公司 用于口服递送的稳定化的溶解性增强的制剂
KR20120034649A (ko) 2009-05-11 2012-04-12 버그 바이오시스템즈, 엘엘씨 환경대사적 전환인자（조효소 ｑ１０）를 사용한 질환의 치료 방법
JP5934102B2 (ja) * 2009-10-30 2016-06-15 レトロトップ、 インコーポレイテッドＲｅｔｒｏｔｏｐｅ， Ｉｎｃ． Ｐｕｆａ誘導体による酸化ストレス障害の緩和
PH12012501806B1 (en) * 2010-03-12 2018-10-26 Berg Llc Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
US20120269867A1 (en) 2011-04-04 2012-10-25 Jimenez Joaquin J Methods of treating central nervous system tumors
KR102111997B1 (ko) 2011-04-26 2020-05-18 레트로토프 인코포레이티드 Ｐｕｆａ와 관련된 신경퇴행성 질환 및 근육 질환
KR102110175B1 (ko) 2011-04-26 2020-05-13 레트로토프 인코포레이티드 Ｐｕｆａ 산화와 관련된 장애
AU2012249921B2 (en) 2011-04-26 2017-06-08 Biojiva Llc Oxidative retinal diseases
WO2012148927A2 (en) 2011-04-26 2012-11-01 Retrotope, Inc. Impaired energy processing disorders and mitochondrial deficiency
US9464016B2 (en) 2011-06-14 2016-10-11 Edison Pharmaceuticals, Inc. Catechol derivatives for treatment of oxidative stress diseases
MX369543B (es) 2011-06-17 2019-11-12 Berg Llc Composiciones farmaceuticas inhalables.
US20140274966A1 (en) * 2013-03-14 2014-09-18 Hygia Pharmaceuticals, Llc Drink Product Containing Genistein and Use Thereof
JP6731336B2 (ja) 2013-04-08 2020-07-29 バーグ エルエルシー コエンザイムｑ１０併用療法を用いた癌の処置方法
AU2014285095A1 (en) * 2013-07-03 2016-02-25 Barrie Tan CoQ10 (ubiquinone, ubiquinol), vitamin A (retinoic acid, retinol), vitamin E (tocotrienol, tocopherol) and methods of use
KR102370843B1 (ko) 2013-09-04 2022-03-04 버그 엘엘씨 코엔자임 q10의 연속주입에 의한 암치료 방법
US9138453B2 (en) 2013-10-14 2015-09-22 Biomarker Pharmaceuticals, Inc. Nutrient combinations for affecting an aging process
US20170189350A1 (en) 2015-11-16 2017-07-06 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
JP7048976B2 (ja) 2015-11-23 2022-04-06 レトロトップ、 インコーポレイテッド １，４－ジエン系の部位特異的同位体標識
DE202015106479U1 (de) 2015-11-29 2016-03-09 Cathleen Straßburger Stapelhilfe und Abdeckhaube für den Transport von Cateringmaterial zum Kunden
CN113024369A (zh) 2015-12-17 2021-06-25 Ptc医疗公司 用于治疗氧化应急障碍的化合物
JP2023514711A (ja) 2020-02-21 2023-04-07 レトロトップ、 インコーポレイテッド 多価不飽和脂肪酸及びその誘導体の同位体修飾方法
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5618914A (en) 1979-07-25 1981-02-23 Eisai Co Ltd Ubidecarenone composition having good absorbability
DE3224619A1 (de) 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung
JP2643217B2 (ja) * 1988-01-22 1997-08-20 エーザイ株式会社 脂溶性物質水性液
US5895652A (en) 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
NO304009B1 (no) * 1997-02-04 1998-10-12 Gunnar Volden Hudpreparat
CA2260397A1 (en) * 1999-01-29 2000-07-29 Atlantis Marine Inc. Method of converting rendered triglyceride oil from marine sources into bland, stable food oil

Also Published As

Publication number Publication date
AR023338A1 (es) 2002-09-04
ES2196874T3 (es) 2003-12-16
IT1304406B1 (it) 2001-03-19
ITBO980596A1 (it) 2000-04-21
WO2000023069A1 (en) 2000-04-27
ATE237323T1 (de) 2003-05-15
US6417233B1 (en) 2002-07-09
EP1123093A1 (en) 2001-08-16
AU1074600A (en) 2000-05-08
DK1123093T3 (da) 2003-08-11
DE69907010T2 (de) 2004-02-19
EP1123093B1 (en) 2003-04-16
DE69907010D1 (de) 2003-05-22
PT1123093E (pt) 2003-09-30

Similar Documents

Publication Publication Date Title
ITBO980596A0 (it) Preparazione per la veicolazione di principi attivi basata su acidi gr assi polinsaturi del gruppo omega 3 .
IT8721453A0 (it) Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche.
PT956013E (pt) Preparacao farmaceutica compreendendo acido eicosapentaenoico e/ou acido estearidonico
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
DE69515533D1 (de) Einen wirkungsfördernden Zusatz enthaltende Estolide, abgeleitet von Triglyceriden, die Hydroxylgruppen enthalten
HUT38892A (en) Process for preparing alpha-, omega-dicarboxylic acids and pharmaceutical compositions comprising the same as active substance
HU903993D0 (en) Process for the preparation of stabilized, cosmetically satisfactory jelly products for the local treatment of acnes
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
IT8021464A0 (it) Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici, procedimento per la loro preparazione e prodotti medicinali che le contengono.
IT8224665A0 (it) Acidi alfa-arilalcanoici e loro derivati in forma otticamente attiva, particolarmente utili come medicamenti e procedimento per laloro preparazione.
IT8220076A0 (it) Procedimento ed apparecchiatura per il trattamento di prodotti di maglieria, in particolare calze.
DZ2202A1 (fr) Procédé de préparation d'énantiomères purs d'acides cyclo-alcano-indol-azaindol-et pyrimido (1,2-a) indol-carbocyclique et leurs dérivés actives.
IT7826849A0 (it) Processo per la preparazione dinitrili di acidi grassi e glicerolo da gliceridi, in particolare da grassi e oli naturali.
FI921717A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-metoksi-10-(1-hydroksietyyli)-11-okso-1-atsatrisyklo/7.2.0.03,8/-undek-2-eeni-2-karboksyylihappojen asyylioksialkyyliestereiden valmistamiseksi
CA2293367A1 (en) Wax esters enriched in .omega.-3 unsaturated fatty acids, their preparation and their use
IT9003728A0 (it) Sali di glicosaminoglicani con esteri di aminoacidi, loro preparazionee formulazioni farmaceutiche che li contengono.
IT8921336A0 (it) Procedimento per la preparazione di elementi strutturali termoisolanti e prodotti cosi' ottenuti.
ZA85353B (en) Branched c10 to c20 fatty acids which are useful as drugs,and process for preparation thereof
IT1112949B (it) Procedimento per la preparazione,in un unico stadio,di idrogenazione di omega-amminoacidi saturi,da omega-aldeido acidi olefinicamente insaturi
IT8219064A0 (it) Procedimento per fabbricare esteri di acidi non saturi.
IT8620737A0 (it) Composizioni farmaceutiche contenenti levodopa metil estere, loro procedimento di preparazione e relative applicazioni terapeutiche.
IT8421648A1 (it) Nuove difluoroepossidoeritromicine, il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i nuovi prodotti
IT8322462A0 (it) Acidi 2, 2-diacilaminocarbossilici esteri basici e ammidi basiche di e procedimento per la loro preparazione.
NO20011499L (no) Fremgangsmåte for fremstilling av 6,6-dialkoksy-5-hydroksy-3- oksoheksansyreestere
IT7827747A0 (it) Processo per la preparazione di esteri non simmetrici di acidi 1,4-diidropiridin-dicarbossilici eloro impiego come farmaci.